Anna Ceribelli
59 works · 1,975 citations · h-index 20
Top works
- Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials
- Phase II Study of Pemetrexed Plus Carboplatin in Malignant Pleural Mesothelioma
- Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma
- Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study
- A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer
- Clinical Implications of KRAS Mutations in Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors: An Important Role for Mutations in Minor Clones
- Prolonged infusion gemcitabine: a clinical phase I study at low- (300 mg/m2) and high-dose (875 mg/m2) levels
- Weekly gemcitabine in advanced or metastatic solid tumors
- Severe rhabdomyolysis associated with pemetrexed-based chemotherapy
- Heterogeneity of PD-L1 Expression and Relationship with Biology of NSCLC
- Does Granulocyte Colony-Stimulating Factor Worsen Anemia in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide?
- Prolonged gemcitabine infusion in advanced non–small cell lung carcinoma
- Safety and Efficacy of Nivolumab in Patients With Advanced Non–small-cell Lung Cancer Treated Beyond Progression
- Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: A tissue micro array-based multicenter study
- Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer?
- The Serine Protease HtrA1 is a Novel Prognostic Factor for Human Mesothelioma
- Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study
- Imatinib mesylate in thymic epithelial malignancies
- PET scanning evaluation of response to imatinib mesylate therapy in gastrointestinal stromal tumor (GIST) patients.
- EGFR Molecular Profiling in Advanced NSCLC: A Prospective Phase II Study in Molecularly/Clinically Selected Patients Pretreated with Chemotherapy